A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg) in postmenarcheal adolescents

Contraception

Volumn 93, Issue 6, 2016, Pages 507-512

  Gemzell Danielsson, Kristina ^a   Buhling, Kai J ^b   Dermout, Sylvia M ^c   Lukkari Lax, Eeva ^d   Montegriffo, Elaine ^e   Apter, Dan ^f  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Department of Gynaecology Gynaecological Centre Dermout and Albicher   (Netherlands)

^d Bayer Oy   (Finland)

^e Bayer plc UK   (United Kingdom)

^f Vaestoliitto   (Finland)

Author keywords

Adolescent; Contraception; Intrauterine contraception; LNG IUS; Nulliparous

Indexed keywords

LEVONORGESTREL; MISOPROSTOL; CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ACNE; ADOLESCENT; ADULT; ARTICLE; CHILD; CONDOM USE; CONTRACEPTION; CYSTITIS; DEVICE SAFETY; DRUG SAFETY; DYSMENORRHEA; ENDOMETRITIS; FEMALE; GASTROENTERITIS; HEADACHE; HUMAN; INFLUENZA; INTRAUTERINE DEVICE EXPULSION; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NAUSEA; NULLIPARA; OUTCOME ASSESSMENT; OVARY CYST; PAIN; PATIENT SATISFACTION; PELVIC PAIN; PHASE 3 CLINICAL TRIAL; RHINOPHARYNGITIS; SINUSITIS; TREATMENT DURATION; URINARY TRACT INFECTION; VAGINA BLEEDING; VAGINITIS; ADVERSE EFFECTS; CLINICAL TRIAL; DEVICE REMOVAL; EUROPE; INTRAUTERINE CONTRACEPTIVE DEVICE; MULTICENTER STUDY; PARITY; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY, ECTOPIC; STATISTICS AND NUMERICAL DATA; UNPLANNED PREGNANCY; UTERINE PERFORATION;

ADOLESCENT; CHILD; CONTRACEPTIVE AGENTS, FEMALE; DEVICE REMOVAL; EUROPE; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; PARITY; PATIENT SATISFACTION; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY, ECTOPIC; PREGNANCY, UNPLANNED; UTERINE PERFORATION;

EID: 84964661190     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2016.02.004     Document Type: Article

References (13)

1. K. Part, C. Moreau, S. Donati, M. Gissler, I. Fronteira, and H. Karro Teenage pregnancies in the European Union in the context of legislation and youth sexual and reproductive health services Acta Obstet Gynecol Scand 92 2013 1395 1406
2. World Health Organization Adolescent Pregnancy. Fact Sheet Number 364 2012 Available from: http://www.who.int/mediacentre/factsheets/fs364/en/ Last accessed November 25, 2015
3. National Institute for Health and Clinical Excellence NICE implementation uptake report: Long-acting Reversible Contraceptives (LARC) 2013 Available from http://www.nice.org.uk/media/67f/c5/uptakereportcg30larc.pdf Last accessed 2015
4. Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices Obstet Gynecol 120 2012 983 988
5. J.R. Rosenstock, J.F. Peipert, T. Madden, Q. Zhao, and G.M. Secura Continuation of reversible contraception in teenagers and young women Obstet Gynecol 120 2012 1298 1305
6. Faculty of Sexual and Reproductive Healthcare FSRH UK medical eligibility criteria for contraceptive use 2009 Available from: http://www.fsrh.org/pdfs/UKMEC2009.pdf Last accessed January 20, 2016
7. American Academy of Pediatrics Contraception for adolescents Pediatrics 134 2014 e1244 e1256
8. World Health Organization Medical eligibility criteria for contraceptive use: fifth edition 2015 World Health Organization Geneva Available from: http://www.who.int/reproductivehealth/publications/family-planning/Ex-Summ-MEC-5/en/ Last accessed January 26, 2016
9. A.L. Nelson, D. Apter, B. Hauck, T. Schmelter, S. Rybowski, K. Rosen, and et al. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial Obstet Gynecol 122 2013 1205 1213
10. Bayer HealthCare Pharmaceuticals Inc Jaydess® Summary of Product Characteristics 2015 Available from: http://www.medicines.org.uk/emc/medicine/28672 Last accessed January 26, 2016
11. E.M. Belsey, D. Machin, and C. d'Arcangues The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction Contraception 34 1986 253 260
12. G.G. Nahum, A.M. Kaunitz, K. Rosen, T. Schmelter, and R. Lynen Ovarian cysts: presence and persistence with use of a 13.5 mg levonorgestrel-releasing intrauterine system Contraception 91 2015 412 417
13. K. Gemzell-Danielsson, D. Apter, B. Hauck, S. Rybowski, T. Schmelter, K. Rosen, and et al. A multicentre, randomized phase III study of two low-dose levonorgestrel intrauterine contraceptive systems: subgroup analyses evaluating efficacy, safety, placement and user satisfaction according to age and parity status PLoS One 10 2015 e0135309